Related references
Note: Only part of the references are listed.3′,4′,5′,5,7-Pentamethoxyflavone Sensitizes Cisplatin-Resistant A549 Cells to Cisplatin by Inhibition of Nrf2 Pathway
Xiangyu Hou et al.
MOLECULES AND CELLS (2015)
Whole-genome characterization of chemoresistant ovarian cancer
Ann-Marie Patch et al.
NATURE (2015)
Tag SNPs in long non-coding RNA H19 contribute to susceptibility to gastric cancer in the Chinese Han population
Chao Yang et al.
ONCOTARGET (2015)
Involvement of SRPK1 in cisplatin resistance related to long non-coding RNA UCA1 in human ovarian cancer cells
F. Wang et al.
NEOPLASMA (2015)
Oncofetal H19 RNA promotes tumor metastasis
Imad J. Matouk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
PCAT-1, a Long Noncoding RNA, Regulates BRCA2 and Controls Homologous Recombination in Cancer
John R. Prensner et al.
CANCER RESEARCH (2014)
Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling
Yu Fan et al.
FEBS JOURNAL (2014)
Down-regulation of Ras-related Protein Rab 5C-dependent Endocytosis and Glycolysis in Cisplatin-resistant Ovarian Cancer Cell Lines
Lixu Jin et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT
Chenchao Ma et al.
TUMOR BIOLOGY (2014)
Overexpression of IncRNA H19 enhances carcinogenesis and metastasis of gastric cancer
Hao Li et al.
ONCOTARGET (2014)
New Insight into P-Glycoprotein as a Drug Target
Albert Breier et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2013)
Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression
Ming Luo et al.
CANCER LETTERS (2013)
Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma
Ling Zhang et al.
CARCINOGENESIS (2013)
Modulation of oxidative stress as an anticancer strategy
Chiara Gorrini et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Ensembl 2013
Paul Flicek et al.
NUCLEIC ACIDS RESEARCH (2013)
The Changing View of High-Grade Serous Ovarian Cancer
Els M. J. J. Berns et al.
CANCER RESEARCH (2012)
Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells
Feng Yang et al.
FEBS JOURNAL (2012)
The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and lgf1r
Andrew Keniry et al.
NATURE CELL BIOLOGY (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
NRF2 and cancer: the good, the bad and the importance of context
Michael B. Sporn et al.
NATURE REVIEWS CANCER (2012)
p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteins
Huimei Yu et al.
EUROPEAN JOURNAL OF CANCER (2011)
Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses
Moran N. Cabili et al.
GENES & DEVELOPMENT (2011)
Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data
M. P. Coleman et al.
LANCET (2011)
Rethinking ovarian cancer: recommendations for improving outcomes
Sebastian Vaughan et al.
NATURE REVIEWS CANCER (2011)
The oncofetal H19 RNA connection: Hypoxia, p53 and cancer
Imad J. Matouk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer
Wing Pui Tsang et al.
CARCINOGENESIS (2010)
A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
Maite Huarte et al.
CELL (2010)
Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation
Cole Trapnell et al.
NATURE BIOTECHNOLOGY (2010)
TopHat: discovering splice junctions with RNA-Seq
Cole Trapnell et al.
BIOINFORMATICS (2009)
Platinum resistance: The role of DNA repair pathways
Lainie P. Martin et al.
CLINICAL CANCER RESEARCH (2008)
Polymorphisms in the H19 Gene and the Risk of Bladder Cancer
Gerald W. Verhaegh et al.
EUROPEAN UROLOGY (2008)
Determination of thiols and disulfides via HPLC quantification of 5-thio-2-nitrobenzoic acid
Wei Chen et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2008)
Elevated glutathione levels confer cellular sensitization to cisplatin toxicity by up-regulation of copper transporter hCtr1
Helen H. W. Chen et al.
MOLECULAR PHARMACOLOGY (2008)
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
Wataru Sakai et al.
NATURE (2008)
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Ali Mortazavi et al.
NATURE METHODS (2008)
The H19 Non-Coding RNA Is Essential for Human Tumor Growth
Imad J. Matouk et al.
PLOS ONE (2007)
Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells
W. P. Tsang et al.
ONCOGENE (2007)
The imprinted H19 noncoding RNA is a primary microRNA precursor
Xuezhong Cai et al.
RNA (2007)
The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis
Dalia Barsyte-Lovejoy et al.
CANCER RESEARCH (2006)
Expression of Bcl-XL in ovarian carcinoma is associated with chemoresistance and recurrent disease
J Williams et al.
GYNECOLOGIC ONCOLOGY (2005)
Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells
AK Holzer et al.
CLINICAL CANCER RESEARCH (2004)
Glutathione depletion restores the susceptibility of cisplatin-resistant chronic myelogenous leukemia cell lines to Natural Killer cell-mediated cell death via necrosis rather than apoptosis
GVZ Dedoussis et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2001)
The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma
I Ariel et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2000)
A family of drug transporters: The multidrug resistance-associated proteins
P Borst et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
